Invention Grant
- Patent Title: Use of La1-like peptide isolated from maurus palmatus venom as an activator of sperm motility in mammals
-
Application No.: US16306289Application Date: 2017-06-01
-
Publication No.: US10729745B2Publication Date: 2020-08-04
- Inventor: Christophe Arnoult , Eric Schmitt , Guillaume Martinez , Pierre Ray
- Applicant: IMV Technologies
- Applicant Address: FR Saint Ouen sur Iton
- Assignee: IMV TECHNOLOGIES
- Current Assignee: IMV TECHNOLOGIES
- Current Assignee Address: FR Saint Ouen sur Iton
- Agency: Browdy and Neimark, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@ebdaab6
- International Application: PCT/EP2017/063340 WO 20170601
- International Announcement: WO2017/207705 WO 20171207
- Main IPC: A61K35/646
- IPC: A61K35/646 ; A61K38/17 ; C07K14/435 ; A61P15/08 ; G01N33/50
Abstract:
The invention relates to a La-1-like peptide agent that increases sperm motility. It is non-toxic and it may be used to treat male infertility in humans, and also to increase fertility in animals. It may be used in artificial reproductive techniques such as in vitro fertilisation (IVF), including intra-cytoplasmic sperm injection (ICSI). The La-1 like peptide agent may also be used in artificial insemination techniques such as intra-cytoplasmic uterine injection (IUI).
Public/Granted literature
- US20190151412A1 USE OF LA1-LIKE PEPTIDE ISOLATED FROM MAURUS PALMATUS VENOM AS AN ACTIVATOR OF SPERM MOTILITY IN MAMMALS Public/Granted day:2019-05-23
Information query
